ACTRN12612000841875尚未招募未知
For a patient with non-alcoholic fatty liver disease, will an isocaloric Mediterranean diet as compared to standard care with a low-fat diet, improve hepatic steatosis and cardiovascular risk factors?
Catherine Properzi0 个研究点目标入组 66 人开始时间: 2012年8月10日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 66
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 70 Years（—）
- 性别
- All
入选标准
- •NAFLD diagnosis with hepatic steatosis (>5.5% as determined by MRS).
- •Weight stability; variation of <5% within the preceding 3-month period.
排除标准
- •Secondary causes of NAFLD.
- •Other causes of liver disease deficiency.
- •Type 2 diabetes mellitus with A1C >8.5% or requiring insulin.
- •Mean alcohol consumption > 20 g/day or 140 g per week in females, >30 g/day or 210 g/week in males.
- •Decompensated liver cirrhosis.
- •Renal failure.
- •Malignancy aside from skin cancer.
- •Current tobacco use.
- •Conditions preventing required assessment or informed consent.
- •Use of weight loss medications.
- •Lipid lowering medications.
- •Fish oil supplement use within the past 3 months.
- •Pregnancy or lactation.
- •Patients unwilling/unable to maintain stable body weight and/or comply with specifically prescribed dietary intake.
研究者
相似试验
招募中
不适用
Establishment of Non-Alcoholic Fatty Liver Disease Cohort for prevention and management of Cardio-cerebrovascular DiseaseDiseases of the digestive systemKCT0007762Seoul Metropolitan Government Seoul National University Boramae Medical Center400
尚未招募
Unknown
se of hsCRP as a marker of severity in patients with non alcoholic fatty liver diseaseCTRI/2024/05/066754Sanju George
尚未招募
不适用
on alcoloholic liver disease in people living with HIVCTRI/2020/01/022630Maulana Azad Medical College
尚未招募
2 期
To study the effect of Safuf-e-Zaranbad in patients with Non-Alcoholic Fatty Liver DiseaseCTRI/2023/03/050355Central Council for Research in Unani Medicine New Delhi
招募中
不适用
Pathophysiology of Non-alcoholic fatty liver disease(NAFLD), multi-center clinical trial by JSG-NAFLDPatients with Non-alcoholic fatty liver disease and healthy volunteerJPRN-UMIN000003872Department of Hepatology, Osaka City University2,000